Company
LeonaBio, Inc. (LONA)
Standardized SEC financial data for LeonaBio, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001620463 · NASDAQ · Biological Products, (No Diagnostic Substances).
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $13.3M | $42.8M | $61.5M | $93.8M | $70.7M | $17.5M |
| SG&A expense | $6.7M | $21.2M | $32.6M | $33.3M | $26.1M | $16.7M |
| Operating income | -$20.0M | -$64.0M |
Standardized from LeonaBio, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $60.6M | $110.5M | $96.0M | $90.6M | $48.4M | $69.3M |
| Total current assets |
Get LONA data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/LONA/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/LONA/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"